Pharma Contractor ApS: Financial statements 2023
CVR: 42247693
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma Contractor ApS (CVR 42247693) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,595,178 and a net result of DKK 1,066,441 compared with DKK 584,810 the year before. That is an increase of 37.3% compared with the year before. Equity in the 2023 report amounted to DKK 1,105,441. The solvency ratio was 67.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,595,178
- Profit/Loss
- DKK 1,066,441
- Equity
- DKK 1,105,441
- Total Assets
- DKK 1,638,275
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma Contractor ApS has published its annual report for 2022. Gross profit came to DKK 1,889,560, and the net result was DKK 584,810.
About Pharma Contractor ApS
Pharma Contractor ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Samina Anwar and Mohammad Masood Anwar. The company is owned by Anwars Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,561,002 and a net result of DKK 1,174,130 compared with DKK 1,438,311 the year before. Equity in the 2025 report amounted to DKK 1,146,081.